Evidence map›Paper›PMID 39182561›Full record

ArticleThe Journal of investigative dermatology2025

Classification of Cutaneous Melanoma and Melanocytic Nevi with MicroRNA Ratios Is Preserved in the Acral Melanoma Subtype.

Dekker C Deacon, Chris Stubben, Eleonora Marcacci, Caroline J Stone, Michael Birdsall, Scott R Florell, Ken Boucher, Douglas Grossman, Robert L Judson-Torres

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of investigative dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Ancestry and somatic profile predict acral melanoma origin and prognosis.medRxiv : the preprint server for health sciences · 2025
    Article
  5. Transdermal delivery of ultradeformable cationic liposomes complexed with miR211-5p (UCL-211) stabilizes BRAFV600E+ melanocytic nevi.Journal of controlled release : official journal of the Controlled Release Society · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dekker C DeaconDepartment of Dermatology, School of Medicine, University of Utah, Salt Lake City, Utah, USA; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA. Electronic address: dekker.deacon@hsc.utah.edu.
Chris StubbenCancer Bioinformatics Shared Resource, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
Eleonora MarcacciSpencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, Utah, USA.
Caroline J StoneSpencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, Utah, USA.
Michael BirdsallSpencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, Utah, USA.
Scott R FlorellDepartment of Dermatology, School of Medicine, University of Utah, Salt Lake City, Utah, USA.
Ken BoucherDepartment of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
Douglas GrossmanDepartment of Dermatology, School of Medicine, University of Utah, Salt Lake City, Utah, USA; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA; Department of Oncological Sciences, School of Medicine, University of Utah, Salt Lake City, Utah, USA.
Robert L Judson-TorresDepartment of Dermatology, School of Medicine, University of Utah, Salt Lake City, Utah, USA; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA; Department of Oncological Sciences, School of Medicine, University of Utah, Salt Lake City, Utah, USA. Electronic address: judsontorreslab@gmail.com.

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 1986 to 2026
$72.6M
Nevus associated microRNAs as mediators of BRAF-induced growth arrest and biomarkers of melanoma progressionR01CA229896 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI JUDSON-TORRES, ROBERT LAIRD · 2021 to 2025
$1.8M
NCI NIH HHS P30 CA042014NCI NIH HHS R01 CA229896
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acral melanomaBiomarkerMelanocytic neviMelanomamicroRNA

Identifiers

PMID39182561
PMCPMC11846704

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.